chr19-10871866-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_199141.2(CARM1):c.164C>A(p.Ala55Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,283,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_199141.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CARM1 | NM_199141.2 | c.164C>A | p.Ala55Glu | missense_variant | 1/16 | ENST00000327064.9 | NP_954592.1 | |
CARM1 | NM_001370088.1 | c.164C>A | p.Ala55Glu | missense_variant | 1/15 | NP_001357017.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CARM1 | ENST00000327064.9 | c.164C>A | p.Ala55Glu | missense_variant | 1/16 | 1 | NM_199141.2 | ENSP00000325690 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151100Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000680 AC: 77AN: 1132680Hom.: 0 Cov.: 31 AF XY: 0.0000710 AC XY: 39AN XY: 549624
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151100Hom.: 0 Cov.: 31 AF XY: 0.0000271 AC XY: 2AN XY: 73760
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.164C>A (p.A55E) alteration is located in exon 1 (coding exon 1) of the CARM1 gene. This alteration results from a C to A substitution at nucleotide position 164, causing the alanine (A) at amino acid position 55 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at